Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment.

Flierl, U; Nero, T L; Lim, B; Andrews, R K; Parker, M W; Gardiner, E E; Peter, K

Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment.

Flierl, U; Nero, T L; Lim, B; Andrews, R K; Parker, M W; Gardiner, E E; Peter, K.

Afiliación

Flierl U; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Nero TL; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Lim B; St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Andrews RK; Bio21 Institute, University of Melbourne, Melbourne, Victoria, Australia.
Parker MW; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Gardiner EE; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Peter K; St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.

J Thromb Haemost ; 16(1): 181-185, 2018 01.

Article en En | MEDLINE | ID: mdl-29052937

Asunto(s)

Lectinas Tipo C; Oligodesoxirribonucleótidos; Activación Plaquetaria

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligodesoxirribonucleótidos / Lectinas Tipo C Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google